BRC News

A third ‘booster’ dose of COVID-19 vaccine successfully raises antibody levels that neutralise the Omicron variant.

It is safe and effective to vaccinate people with inflammatory or autoimmune rheumatic and musculoskeletal diseases such as arthritis and lupus, a study led by UCL has found.

UCLH clinicians and researchers are to test a novel way of running clinical trials using the hospital’s electronic health records system.

A new CAR T-cell therapy developed by scientists at UCL has fewer ‘toxic’ side-effects and is more durable, targeting and killing cancer cells for longer, concludes a Phase 1 clinical trial of patients at UCLH.

Adding the hormone therapy abiraterone to the standard treatment for locally advanced prostate cancer, where the cancer has a high chance of spreading, could halve the risk of death.

UCL researchers have identified up to 23 genes which could be targeted by drugs to treat Parkinson’s disease.

Cheap portable air filters could cut Covid-19 transmission in hospitals and be a simple way to reduce hospital waiting times as a result of the pandemic, according to UCL and UCLH research.

People who were hospitalised with COVID-19 and continued to experience symptoms at five months show limited further recovery one year after hospital discharge, according to the latest results of the PHOSP (Post-Hospitalisation) COVID study.

A framework for quantifying the equity of access to healthcare research has been developed at UCLH and UCL.

Six COVID-19 vaccines are safe and boost immunity for people who have had two doses of AstraZeneca or Pfizer-BioNTech, results from the UK-wide COV-BOOST trial show.

Innovative technology to help older people with balance disorders can significantly improve patients’ balance, their ability to perform everyday tasks and their social wellbeing.

UCL academic Professor Brian Hutton has been awarded the prestigious Peter Mansfield Medal and Prize by the Institute of Physics (IOP) for his distinguished contributions to the field of medical physics.

UCL researchers have for the first time found evidence that cross-sex hormone treatment – given to people who are transitioning genders – induces changes in fat metabolism that require further exploration.

A world-first study at UCLH and UCL has shown that whole genome sequencing (WGS) can uncover new diagnoses for people across the broadest range of rare diseases investigated to date and could deliver enormous benefits for the NHS.

UCLH and UCL clinician scientist Professor Charles Swanton has been awarded the prestigious Memorial Sloan Kettering Cancer Center’s 2021 Paul Marks Prize for Cancer Research.